Summary

Persistence Market Research has recently released a comprehensive report on the global animal drug compounding market. The report delivers an in-depth assessment of key market dynamics, including growth drivers, trends, opportunities, and challenges, while offering detailed insights into the market’s structure and competitive landscape. This research publication presents exclusive data and statistics highlighting the expected growth trajectory of the global animal drug compounding market from 2025 to 2032.

Key Insights:

• Animal Drug Compounding Market Size (2025E): US$ 1.4 Billion
• Projected Market Value (2032F): US$ 2.2 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 6.6%

Animal Drug Compounding Market – Report Scope:

Animal drug compounding involves creating customized medications tailored to the specific health needs of animals, ranging from companion pets to livestock. These formulations include CNS agents, anti-infective agents, hormones and substitutes, and anti-inflammatory agents. They are available in oral and injectable forms, ensuring flexible administration for diverse veterinary requirements. Rising trends in pet humanization and the demand for specialized veterinary treatments are driving market expansion. The market is further supported by advancements in compounding technologies and the increasing focus on animal health and wellness.

Market Growth Drivers:

The global animal drug compounding market is propelled by the growing trend of pet humanization, where pet owners demand customized medications that match the sophistication of human pharmaceuticals. Increasing prevalence of chronic and lifestyle-related diseases in companion animals, coupled with awareness of preventive healthcare, is boosting demand for compounded drugs. Additionally, livestock producers are adopting compounding solutions for enhanced animal productivity, disease prevention, and tailored nutrition support. Technological advancements in compounding pharmacies and improved veterinary healthcare infrastructure further enhance market growth.

Market Restraints:

Despite significant growth opportunities, the animal drug compounding market faces challenges related to regulatory compliance and standardization. Variability in veterinary drug regulations across regions can complicate production and distribution. High costs associated with specialized formulations and limited awareness in emerging markets may also hinder adoption. Furthermore, concerns regarding quality control and safety in compounded drugs present operational challenges for manufacturers.

Market Opportunities:

The market presents substantial opportunities through the expansion of veterinary healthcare services in emerging regions. Increasing adoption of advanced drug delivery systems, novel formulations, and personalized medicine approaches for pets offers new revenue streams. Strategic collaborations between veterinary hospitals, pharmacies, and pharmaceutical manufacturers are creating avenues for market penetration. Additionally, rising awareness of animal welfare and proactive health management is expected to accelerate demand for compounding solutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the animal drug compounding market globally?
• Which animal types and product segments are generating the highest demand?
• How are advancements in compounding technologies influencing market dynamics?
• Who are the leading players in the animal drug compounding market, and what strategies are they adopting?
• What are the emerging trends and future growth opportunities across regional markets?

Competitive Intelligence and Business Strategy:

Leading players in the global animal drug compounding market focus on product innovation, quality assurance, and geographic expansion to strengthen their market position. Companies invest in R&D to develop safer, more effective, and customized formulations. Strategic partnerships with veterinary clinics, hospitals, and distributors help expand market reach. Mergers, acquisitions, and regional expansions remain key strategies to gain competitive advantage and address evolving veterinary needs.

Key Companies Profiled:

• Hoye's Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Dougherty's Pharmacy
• Triangle Compounding Pharmacy Inc.
• Medisca Inc.
• Wedgewood Pharmacy
• Millers Pharmacy
• Chiron Compounding Pharmacy
• MEDS Canadian Compounding Pharmacy
• Aurora Compounding
• Pace Pharmacy
• Victoria Compounding Pharmacy
• Pratt’s Compounding Pharmacy
• People’s Choice Pharmacy

Animal Drug Compounding Market Research Segmentation:

By Product

• CNS Agents
• Anti-Infective Agents
• Hormones and Substitutes
• Anti-inflammatory Agents

By Animal Type

• Companion Animals
• Livestock

By Formulation

• Oral
• Injectable

By Region

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Animal Drug Compounding Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Value Chain Analysis
3.2. Technology Assessment
3.3. Product Adoption / Usage Analysis
3.4. Key Market Players
3.5. Regulatory Landscape
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Global Animal Drug Compounding Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024–2032
4.3. Global Animal Drug Compounding Market Outlook: Product
4.3.1. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
4.3.2. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
4.3.2.1. CNS Agents
4.3.2.2. Anti-Infective Agents
4.3.2.3. Hormones and Substitutes
4.3.2.4. Anti-Inflammatory Agents
4.3.2.5. Others
4.3.3. Market Attractiveness Analysis: Product
4.4. Global Animal Drug Compounding Market Outlook: Animal
4.4.1. Historical Market Size (US$ Bn) Analysis, By Animal, 2019-2024
4.4.2. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
4.4.2.1. Companion
4.4.2.1.1. Cats
4.4.2.1.2. Dogs
4.4.2.1.3. Others
4.4.2.2. Livestock
4.4.3. Market Attractiveness Analysis: Animal
4.5. Global Animal Drug Compounding Market Outlook: Formulation
4.5.1. Historical Market Size (US$ Bn) Analysis, By Formulation, 2019-2024
4.5.2. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
4.5.2.1. Oral
4.5.2.2. Injectable
4.5.2.3. Others
4.5.3. Market Attractiveness Analysis: Formulation
5. Global Animal Drug Compounding Market Outlook: Region
5.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.2. Current Market Size (US$ Bn) and Forecast Analysis, By Region, 2024–2032
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. East Asia
5.2.5. South Asia and Oceania
5.2.6. Middle East & Africa
5.3. Market Attractiveness Analysis: Region
6. North America Animal Drug Compounding Market Outlook
6.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.1.1. By Country
6.1.2. By Product
6.1.3. By Animal
6.1.4. By Formulation
6.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
6.2.1. U.S.
6.2.2. Canada
6.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
6.3.1. CNS Agents
6.3.2. Anti-Infective Agents
6.3.3. Hormones and Substitutes
6.3.4. Anti-Inflammatory Agents
6.3.5. Others
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
6.4.1. Companion
6.4.1.1. Cats
6.4.1.2. Dogs
6.4.1.3. Others
6.4.2. Livestock
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
6.5.1. Oral
6.5.2. Injectable
6.5.3. Others
6.6. Market Attractiveness Analysis
7. Europe Animal Drug Compounding Market Outlook
7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.1.1. By Country
7.1.2. By Product
7.1.3. By Animal
7.1.4. By Formulation
7.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
7.2.1. Germany
7.2.2. France
7.2.3. U.K.
7.2.4. Italy
7.2.5. Spain
7.2.6. Russia
7.2.7. Rest of Europe
7.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
7.3.1. CNS Agents
7.3.2. Anti-Infective Agents
7.3.3. Hormones and Substitutes
7.3.4. Anti-Inflammatory Agents
7.3.5. Others
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
7.4.1. Companion
7.4.1.1. Cats
7.4.1.2. Dogs
7.4.1.3. Others
7.4.2. Livestock
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
7.5.1. Oral
7.5.2. Injectable
7.5.3. Others
7.6. Market Attractiveness Analysis
8. East Asia Animal Drug Compounding Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Product
8.1.3. By Animal
8.1.4. By Formulation
8.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
8.2.1. China
8.2.2. Japan
8.2.3. South Korea
8.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-Inflammatory Agents
8.3.5. Others
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
8.4.1. Companion
8.4.1.1. Cats
8.4.1.2. Dogs
8.4.1.3. Others
8.4.2. Livestock
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
8.5.1. Oral
8.5.2. Injectable
8.5.3. Others
8.6. Market Attractiveness Analysis
9. South Asia & Oceania Animal Drug Compounding Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Product
9.1.3. By Animal
9.1.4. By Formulation
9.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
9.2.1. India
9.2.2. Indonesia
9.2.3. Thailand
9.2.4. Singapore
9.2.5. ANZ
9.2.6. Rest of South Asia & Oceania
9.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
9.3.1. CNS Agents
9.3.2. Anti-Infective Agents
9.3.3. Hormones and Substitutes
9.3.4. Anti-Inflammatory Agents
9.3.5. Others
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
9.4.1. Companion
9.4.1.1. Cats
9.4.1.2. Dogs
9.4.1.3. Others
9.4.2. Livestock
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
9.5.1. Oral
9.5.2. Injectable
9.5.3. Others
9.6. Market Attractiveness Analysis
10. Latin America Animal Drug Compounding Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Product
10.1.3. By Animal
10.1.4. By Formulation
10.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
10.3.1. CNS Agents
10.3.2. Anti-Infective Agents
10.3.3. Hormones and Substitutes
10.3.4. Anti-Inflammatory Agents
10.3.5. Others
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
10.4.1. Companion
10.4.1.1. Cats
10.4.1.2. Dogs
10.4.1.3. Others
10.4.2. Livestock
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
10.5.1. Oral
10.5.2. Injectable
10.5.3. Others
10.6. Market Attractiveness Analysis
11. Middle East & Africa Animal Drug Compounding Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Product
11.1.3. By Animal
11.1.4. By Formulation
11.2. Current Market Size (US$ Bn) Analysis and Forecast by Country, 2024–2032
11.2.1. GCC Countries
11.2.2. Egypt
11.2.3. South Africa
11.2.4. Northern Africa
11.2.5. Rest of Middle East & Africa
11.3. Current Market Size (US$ Bn) and Forecast Analysis, By Product, 2024–2032
11.3.1. CNS Agents
11.3.2. Anti-Infective Agents
11.3.3. Hormones and Substitutes
11.3.4. Anti-Inflammatory Agents
11.3.5. Others
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Animal, 2024–2032
11.4.1. Companion
11.4.1.1. Cats
11.4.1.2. Dogs
11.4.1.3. Others
11.4.2. Livestock
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2024–2032
11.5.1. Oral
11.5.2. Injectable
11.5.3. Others
11.6. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping by Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Hoye's Pharmacy
12.3.1.1. Overview
12.3.1.2. Segments and Sources
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Vertisis Custom Pharmacy
12.3.3. Smith Caldwell Drug Store
12.3.4. Sixth Avenue Medical Pharmacy
12.3.5. Dougherty's Pharmacy
12.3.6. Triangle Compounding Pharmacy Inc.
12.3.7. Medisca Inc.
12.3.8. Wedgewood Pharmacy
12.3.9. Millers Pharmacy
12.3.10. Chiron Compounding Pharmacy
12.3.11. MEDS Canadian Compounding Pharmacy
12.3.12. Aurora Compounding
12.3.13. Pace Pharmacy
12.3.14. Victoria Compounding Pharmacy
12.3.15. Pratt’s Compounding Pharmacy
12.3.16. People’s Choice Pharmacy
12.3.17. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations